Concepedia
Statistics
Publications
7
Citations
263
H-Index
Active since
2020
Affiliations
Vall d'Hebron Hospital Universitari(Current)
Janssen (United Kingdom)
Janssen (United States)
Sarah Cannon
Vall d'Hebron Institut de Recerca
Jaydeep Mehta is an author at Vall d'Hebron Hospital Universitari specializing in medicine, pharmacology, and neoplasia.
Publications per year
2020–2025
Overall Survival with Amivantamab–Lazertinib in <i>EGFR</i> -Mutated Advanced NSCLC
James Chih‐Hsin Yang, Shun Lu, Hidetoshi Hayashi et al. · New England Journal of Medicine · 2025 · 85 citations
Medicine, Oncology, Pharmacology +15
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors
María Vieito, Víctor Moreno, Anna Spreafico et al. · Clinical Cancer Research · 2023 · 77 citations
Medicine, Pharmacokinetics, Pharmacology +17
537MO First-in-human study of JNJ-64619178, a protein arginine methyltransferase 5 (PRMT5) inhibitor, in patients with advanced cancers
Anna Spreafico, Víctor Moreno, Irene Braña et al. · Annals of Oncology · 2020 · 31 citations
Medicine, Oncology, Pharmacology +5
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Patients with Lower-Risk Myelodysplastic Syndromes
Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Blood · 2021 · 20 citations
Medicine, Pharmacology, Pharmacotherapy +6
Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes
Tamanna Haque, Félix López Cadenas, Blanca Xicoy et al. · Leukemia Research · 2023 · 19 citations
1–5 of 7